Tempus AI Inc (TEM) USD0.0001 A

Sell:$46.82Buy:$46.86Price decreased$1.61 (3.32%)

NASDAQ:Price decreased1.13%
Market closed |
Prices delayed by at least 15 minutes
Sell:$46.82
Buy:$46.86
Change:Price decreased$1.61 (3.32%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$46.82
Buy:$46.86
Change:Price decreased$1.61 (3.32%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Key people

Eric P. Lefkofsky
Chairman of the Board, Chief Executive Officer, Founder
David R. Epstein
Independent Director
Wayne A.I. Frederick
Independent Director
James Rogers
Chief Financial Officer
Ryan Fukushima
Chief Executive Officer - Data
Tom Schoenherr
Chief Executive Officer - Diagnostics
Andrew Polovin
Executive Vice President, Chief Legal Officer and Secretary
Erik J. Phelps
Chief Administrative Officer
Peter J. Barris
Independent Director
Eric D. Belcher
Independent Director
Jennifer A. Doudna
Independent Director
Click to see more

Key facts

  • Shares in issue
    174.70m
  • EPIC
    TEM
  • ISIN
    US88023B1035
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $8.95bn
  • Employees
    3,800
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.